Analysts at Stephens & Co. initiated coverage on Tribune Media Co TRCO with a Equal-weight rating. The target price for Tribune Media is set to $42. Tribune Media shares closed at $36.19 on Tuesday.
Analysts at Goldman Sachs initiated coverage of BioMarin Pharmaceutical Inc. BMRN with a Buy rating. The target price for BioMarin Pharmaceutical is set to $158. BioMarin Pharmaceutical shares closed at $107.32 on Tuesday.
Piper Jaffray initiated coverage of Align Technology, Inc. ALGN with a Overweight rating. The target price for Align Technology is set to $74. Align Technology shares closed at $65.28 on Tuesday.
Analysts at Bank of America initiated coverage on Allegion PLC ALLE with a Buy rating. The target price for Allegion is set to $75. Allegion shares closed at $64.59 on Tuesday.
JP Morgan initiated coverage on Fulton Financial Corp FULT with a Neutral rating. The target price for Fulton Financial is set to $14.50. Fulton Financial shares closed at $14.08 on Tuesday.
Stephens & Co. initiated coverage on Meredith Corporation MDP with a Equal-weight rating. The target price for Meredith is set to $50. Meredith shares closed at $45.67 on Tuesday.
Goldman Sachs initiated coverage on ISIS Pharmaceuticals, Inc. ISIS with a Neutral rating. The target price for ISIS Pharmaceuticals is set to $65. ISIS Pharmaceuticals shares closed at $61.32 on Tuesday.
Analysts at Citigroup initiated initiated coverage on Halozyme Therapeutics, Inc. HALO with a Buy rating. The target price for Halozyme Therapeutics is set to $25. Halozyme Therapeutics shares closed at $15.64 on Tuesday.
Analysts at Wunderlich initiated coverage on Inventure Foods Inc SNAK with a Buy rating. The target price for Inventure Foods is set to $13. Inventure Foods shares closed at $6.92 on Tuesday.
Analysts at BB&T Capital initiated coverage on OSI Systems, Inc. OSIS with a Buy rating. The target price for OSI Systems is set to $103. OSI Systems shares closed at $85.34 on Tuesday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in